Phase out D4T in poor countries

Stavudine (D4T) was previously one of three antiretroviral drugs (ARVs) recommended as first-line treatment but serious side effects, seen in many studies and treatment programmes, led to calls to use better, less toxic drugs.Click here to read more on Quackdown.

Author

  • Health-e News

    Health-e News is South Africa's dedicated public health news service and home to OurHealth citizen journalism. Follow us on Twitter @HealtheNews

    View all posts

Support Our Work. Make A Donation

Donate Here!

Free to Share

Creative Commons License

Republish our articles for free, online or in print, under a Creative Commons license.


Newsletter Subscription

loading
Enable Notifications OK No thanks